(Q43781342)

English

Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats

scientific article published on 30 August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Masahiro Noguchi

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Aishi Kimoto

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Masao Sasamata

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Keiji Miyata

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

30 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Journal of Bone and Mineral Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

461-468

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Bone loss in inflammatory arthritis: mechanisms and treatment strategies

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

An Essential Role of Cytosolic Phospholipase A2α in Prostaglandin E2–mediated Bone Resorption Associated with Inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Pharmacological analysis of cyclooxygenase-1 in inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Enzymologic and pharmacologic profile of loxoprofen sodium and its metabolites

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Effect of celecoxib, a cyclooxygenase-2 inhibitor, on the pathophysiology of adjuvant arthritis in rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Contribution of trabecular and cortical components to the mechanical properties of bone and their regulating parameters.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Trabecular bone pattern factor--a new parameter for simple quantification of bone microarchitecture

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Multi-detector row CT imaging of vertebral microstructure for evaluation of fracture risk.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Human osteoclast formation and activity in vitro: effects of alendronate.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a topically acting antiglaucoma sulfonamide

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Suppression of adjuvant-induced arthritic bone destruction by cyclooxygenase-2 selective agents with and without inhibitory potency against carbonic anhydrase II.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0855-3

21 January 2018

Induction of cyclooxygenase II in human synovial microvessel endothelial cells by interleukin-1. Inhibition by glucocorticoids

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of arthritis, periarthritis and periostitis in rats given adjuvants

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of methotrexate therapy on bone mineral density and body composition in rat adjuvant arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone destruction in arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin endoperoxide H synthases-1 and -2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-1-Induced Prostaglandin E2 Biosynthesis in Human Synovial Cells Involves the Activation of Cytosolic Phospholipase A2 and Cyclooxygenase-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthritic cartilage

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two distinct actin-binding sites of smooth muscle calponin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system

1 reference

https://pubmed.ncbi.nlm.nih.gov/18758904

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00774-008-0855-3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43781342&oldid=2206254740"